DHA supplementation prevent the progression of NASH via GPR120 signaling

Nakamoto, K; Shimada, K; Harada, S; Morimoto, Y; Hirasawa, A; Tokuyama, S

Tokuyama, S (reprint author), Kobe Gakuin Univ, Dept Clin Pharm, Sch Pharmaceut Sci, Chuo Ku, 1-1-3 Minatojima, Kobe, Hyogo 6508586, Japan.

EUROPEAN JOURNAL OF PHARMACOLOGY, 2018; 820 (): 31

Abstract

Nonalcoholic steatohepatitis (NASH) is one of the most common liver diseases involving chronic accumulation of fat and inflammation, often leading to ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索